SHL Telemedicine Ltd. develops and markets personal telemedicine systems and provides medical call center services for cardiovascular and related diseases. Its recurring company updates center on SmartHeart®, a portable 12-lead ECG platform used for at-home and mobile cardiovascular assessment, along with subscriber-based telemedicine services that use telephone and internet communications.
News about SHL Telemedicine also covers direct-to-consumer cardiac care offerings, cardiologist-reviewed ECG workflows, at-home biomarker blood testing in Israel, healthcare partnerships, clinical study results, military and mobile-care deployments, regional operating results and leadership or governance updates. The company is listed on Nasdaq under SHLT and on the SIX Swiss Exchange under SHLTN.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.